Plus   Neg

Collegium Pharmaceutical Holding On To Significant Gain

Shares of Collegium Pharmaceutical (COLL) have pulled back off their best levels of the day but continue to see significant strength in afternoon trading on Thursday. Collegium is currently up by 11.8 percent after reaching a two-month intraday high.

The jump comes after Cigna (CI) said it has signed a value-based contract with Collegium Pharmaceutical for its oxycodone equivalent Xtampza ER after ending coverage of opioid painkiller OxyContin.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Angry protesters are planning more than 50 demonstrations on Friday at several Tim Hortons locations across Canada after some franchise owners in Ontario slashed workers' benefits as well as paid breaks in response to the Ontario government's minimum wage hike. The protests are being organized by advocacy group Leadnow and the Fight for $15 & Fairness Campaign. Athletic footwear giant Nike, Inc. on Thursday announced a new marketing head, in its efforts to boost market share. The company promoted Dirk-Jan "DJ" van Hameren as its VP, Chief Marketing Officer, effective immediately. Van Hameren will succeed Greg Hoffman, who has been appointed VP, Global Brand Creative & Marketing Innovation Amazon.com Inc. (AMZN) said Thursday that it has chosen the 20 metropolitan areas to move to the next phase of the selection process for the company's second headquarters. The company plans to invest over $5 billion and grow the second headquarters to accommodate as many as 50,000 high-paying jobs.
comments powered by Disqus
Follow RTT